NIVO in PAP
02 Dec 2020
NIVO PAP
NCT03804554
Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
Bristol-Myers Squibb
Cancer Type | Lung & mesothelioma |
---|---|
Trial Type | Early detection, diagnosis, prognosis |
Phase | All phases |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | Non-small Cell Lung Cancer |
Cancer Stage | All stages |
Anticipated Start Date | 2018-10-03 |
Anticipated End Date | 2020-12-01 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Michael Brown |
Recruitment Status | Recruiting |